LamassuBiotech
  • Company
    • Mission & History
    • Leadership & Key Collaborators
    • Partners
  • The Lamassu Method
  • Pipeline
    • SA53
    • RABI-767
  • Lamassu Pets
  • Investor Resources
    • Investor Resources
    • Events & Presentations
  • News
    • News Releases
    • Media Coverage
  • Contact Us

Category: media

08/05/2020

Bio-IT World: Follow the Money: Cash for AI Models, Oncology, Hematology Therapies

Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. Glioblastoma, hematology, and acute pancreatitis all see new funding for therapy development. And AI-powered models net cash.    $1.5M:...
READ THE ARTICLE
03/30/2020

Healthcare Boss: Jason A. Duprat Speaks with Lamassu CEO Dr. Gabi Hanna MD About Navigating Intellectual Property & Entrepreneurship

Dr. Gabi Hanna, a physician entrepreneur with more than 15 years of leadership experience in early drug development and the Executive Director at Duke Preclinical Translational Research Unit speaks with...
READ THE ARTICLE

Posts navigation

Newer posts

Recent Posts

  • Crain’s Cleveland Business: Former FDA leader appointed to Lamassu Biotech board of directors
  • FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS
  • Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs
  • RBV Quarterly: CEO Insights: Dr Gabi Hanna, Lamassu Biotech
  • SA53 MDM2 Inhibitor: Lamassu Biotech Reports Significant Progress and Favorable Safety Profile in Phase 1/2a Clinical Trial

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • January 2026
  • November 2025
  • October 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • February 2025
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • April 2021
  • August 2020
  • March 2020

Categories

  • media
  • news
  • Uncategorized

Menu

  • Investor Resources
  • News Releases
  • Contact us

Questions?

1-919-246-3969

info@lamassubio.com

  • Privacy Statement
  • Terms Of Use
  • Accessibility
  • FCOI Policies